Cure My Disease

Don't miss your cure!

 Log in / Sign up

Team-Based care may cut hospital readmissions for a common heart failure

NCT ID NCT07798856

Disease control Sponsor: Chimei Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This trial tests whether a coordinated care team, including cardiologists, pharmacists, dietitians, and rehabilitation specialists, can improve outcomes for people hospitalized with heart failure with preserved ejection fraction (HFpEF). Participants receive structured follow-up, medication review, dietary and lifestyle counseling, and exercise guidance. Researchers compare their hospital stay length, readmission rates, and quality of life against a historical group that received standard care. The goal is to see if this integrated approach reduces hospitalizations and improves daily living for a condition with limited treatment options.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multidisciplinary Integrated Care Model (MICM), a structured team-based care program including cardiology management, case management, pharmacist-led medication review, nutritional counseling, and exercise guidance
What this could lead to
If it works, this integrated care approach could reduce hospital readmissions and improve quality of life for people with HFpEF, a condition with few effective treatments.
What could go wrong
This is a quasi-experimental study with a historical control group, which is less reliable than a randomized trial. The results may be influenced by differences between the groups, and the intervention may not be widely applicable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Hospitalized with a physician diagnosis of heart failure with preserved ejection fraction (HFpEF) * Left ventricular ejection fraction (LVEF) ≥50% on echocardiography performed during the index hospitalization * New York Heart Association (NYHA) functional class III to IV * Able to communicate in Mandarin or Taiwanese and understand the study intervention * For the prospective intervention group: willing to participate and provide written informed consent. For the historical control group: existing medical record data will be collected under a waiver of informed consent. Exclusion Criteria: * Patients who elected hospice or palliative care as part of an advance care plan during the index hospitalization * Severe cognitive impairment without a family member or caregiver available to assist with the digital platform * Anticipated inability to complete post-discharge follow-up or lack of regular follow-up at the study institution's outpatient clinic * Length of index hospital stay less than 24 hours

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diastolic heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure Heart failure with preserved ejection fraction (hfpef)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Chi Mei Medical Center

    Tainan, Yongkang Dist, 71004, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.